Sheel Biotech Limited (NSE:SHEEL)
India · Delayed Price · Currency is INR 60.00
0.00 (0.00%)
At close: Oct 5, 2026
Sheel Biotech Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 1,221 | 814 | - | - | - | - | |
Market Cap Growth | - | - | - | - | - | - |
Enterprise Value | 1,219 | 1,083 | - | - | - | - |
Last Close Price | 60.00 | 40.00 | - | - | - | - |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 8.97 | 6.93 | - | - | - | - |
PS Ratio | 1.11 | 0.74 | - | - | - | - |
PB Ratio | 0.96 | 0.64 | - | - | - | - |
P/TBV Ratio | 0.96 | 0.64 | - | - | - | - |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 1.11 | 0.98 | - | - | - | - |
EV/EBITDA Ratio | 5.84 | 5.19 | - | - | - | - |
EV/EBIT Ratio | 6.15 | 5.46 | - | - | - | - |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.07 | 0.07 | 0.21 | 0.32 | 0.30 | 0.39 |
Debt / EBITDA Ratio | 0.43 | 0.43 | 1.16 | 1.62 | 2.17 | 3.64 |
Debt / FCF Ratio | - | - | 2.39 | - | 2.36 | 24.04 |
Net Debt / Equity Ratio | 0.00 | 0.00 | 0.18 | 0.30 | 0.28 | 0.39 |
Net Debt / EBITDA Ratio | -0.01 | -0.01 | 1.02 | 1.49 | 2.00 | 3.60 |
Net Debt / FCF Ratio | 0.01 | 0.01 | 2.10 | -17.89 | 2.17 | 23.72 |
Asset Turnover | 0.86 | 0.86 | 0.94 | 0.92 | 0.86 | 0.81 |
Inventory Turnover | 2.01 | 2.01 | 1.82 | 2.21 | 3.48 | 5.28 |
Quick Ratio | 5.33 | 5.33 | 2.59 | 2.63 | 2.80 | 3.43 |
Current Ratio | 7.53 | 7.53 | 4.49 | 4.22 | 4.04 | 4.22 |
Return on Equity (ROE) | 11.15% | 11.15% | 13.74% | 15.38% | 8.20% | 8.30% |
Return on Assets (ROA) | 9.63% | 9.63% | 8.12% | 8.48% | 5.22% | 3.94% |
Return on Invested Capital (ROIC) | 13.11% | 14.71% | 12.23% | 13.19% | 7.56% | 7.05% |
Return on Capital Employed (ROCE) | 15.40% | 15.40% | 15.80% | 16.30% | 10.70% | 7.40% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Oct '26 Oct 2, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 9.63% | 14.44% | - | - | - | - |
FCF Yield | -19.84% | -29.76% | - | - | - | - |
Payout Ratio | - | - | 13.90% | 12.66% | 25.30% | 26.45% |
Buyback Yield / Dilution | -18.94% | -18.94% | -1.86% | - | - | -250.00% |
Total Shareholder Return | -18.94% | -18.94% | -1.86% | - | - | -250.00% |